MODIFIED VACCINIA VIRUS ANKARA-85A ANTIGEN
UNII H0QZ75H2XY

Substance Identification & Data

This profile provides standardized clinical and technical data for Modified Vaccinia Virus Ankara-85a Antigen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H0QZ75H2XY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2171576-44-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
H0QZ75H2XY
CAS Registry Number
2171576-44-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MODIFIED VACCINIA VIRUS ANKARA-85A ANTIGEN
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Modified Vaccinia Virus Ankara-85a Antigen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

MODIFIED VACCINIA VIRUS ANKARA-85A ANTIGEN
MODIFIED VACCINIA VIRUS ANKARA-MYCOLYL TRANSFERASE 85A (MYCOBACTERIUM TUBERCULOSIS H37RV) EXPRESSING VIRUS
MVA85A
MVA-85A

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record